Therapeutic monitoring of mycophenolate in transplantation: is it justified?
about
Mycophenolate fetal toxicity and risk evaluation and mitigation strategiesClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationThe influence of UGT polymorphisms as biomarkers in solid organ transplantationThe correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receiptsSteady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort studyBK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Pharmacogenetic influences on mycophenolate therapy.Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy.A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients.
P2860
Q26822840-14E73FAF-1041-451A-A6C1-B0387029F60BQ26998832-9FECEB5A-3878-4B27-BE9A-2912AC81BAF8Q27009825-D6B8A501-6A4C-4CC6-BEFE-9C8A9E71CB3BQ33793971-64BF6031-C53D-4779-9AE4-8677B915CBD7Q34614033-13FF45A6-28F5-44C0-9F31-479AFA483BC0Q35099077-8315DBF5-FA11-497B-A6C0-4C2B95DD8067Q35112606-0877A3CA-181F-4EB1-AB9A-B578B47C04DFQ36777485-628862C7-05F3-4A5E-9E12-93C8E6CCEAE2Q37710509-E227666D-7EBE-43B8-8713-109393AE2D65Q37956717-627C5D34-E8B3-4C08-8192-60852F6A6B29Q38208983-7B09A74B-BA95-4634-90AA-0FB9D4B14FF9Q39622403-255E892D-1C69-403F-B963-A6A56C4518B1Q43139172-407E6EB9-47DE-4A29-A610-267E56B4D417Q51368572-92864450-F0C3-4CF0-A329-D74A7D794250Q51425238-EC294F8D-9505-4792-BE19-FD9081B5490DQ53093650-39B5D7EE-520F-4F87-992F-D9B081774F12
P2860
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@en
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@nl
type
label
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@en
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@nl
prefLabel
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@en
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@nl
P1476
Therapeutic monitoring of mycophenolate in transplantation: is it justified?
@en
P2093
Katherine Ann Barraclough
Nicole Maree Isbel
P304
P356
10.2174/138920009787522205
P407
P577
2009-02-01T00:00:00Z